SKYSTAR BIO-PHARMACEUTICAL CO Net Cash Provided by (Used in) Operating Activities, Continuing Operations
SKYSTAR BIO-PHARMACEUTICAL CO reported Net Cash Provided by (Used in) Operating Activities, Continuing Operations of $15.24 million for the 9-month period ending 2014-09-30, per its 10-Q filed 2014-11-14.
Discontinued › Cash Flow › Operating Activities
us-gaap:NetCashProvidedByUsedInOperatingActivitiesContinuingOperations · last filed 2014-11-14
- SKYSTAR BIO-PHARMACEUTICAL CO net cash provided by (used in) operating activities, continuing operations for the quarter ending 2014-09-30 was $5.23M, a 238.91% increase year-over-year.
- SKYSTAR BIO-PHARMACEUTICAL CO net cash provided by (used in) operating activities, continuing operations for the quarter ending 2014-06-30 was $5.42M.
- SKYSTAR BIO-PHARMACEUTICAL CO net cash provided by (used in) operating activities, continuing operations for the quarter ending 2014-03-31 was $4.60M.
- SKYSTAR BIO-PHARMACEUTICAL CO net cash provided by (used in) operating activities, continuing operations for the quarter ending 2013-12-31 was $3.67M.
- SKYSTAR BIO-PHARMACEUTICAL CO net cash provided by (used in) operating activities, continuing operations for fiscal 2013 was -$5.42M, a 182.85% decline from fiscal 2012.
- SKYSTAR BIO-PHARMACEUTICAL CO net cash provided by (used in) operating activities, continuing operations for fiscal 2012 was $6.55M.
| Period end | Net Cash Provided by (Used in) Operating Activities, Continuing Operations 3 month | Net Cash Provided by (Used in) Operating Activities, Continuing Operations 6 month | Net Cash Provided by (Used in) Operating Activities, Continuing Operations 9 month | Net Cash Provided by (Used in) Operating Activities, Continuing Operations 12 month |
|---|---|---|---|---|
| 2014-09-30 | $5.23M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-14 | $10.65M derived: sum of 2 quarters · filed 2014-11-14 | $15.24M 10-Q · filed 2014-11-14 | $18.91M derived: sum of 4 quarters · filed 2014-11-14 |
| 2014-06-30 | $5.42M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-14 | $10.02M 10-Q · filed 2014-08-14 | $13.69M derived: sum of 3 quarters · filed 2014-08-14 | $15.23M derived: sum of 4 quarters · filed 2014-11-14 |
| 2014-03-31 | $4.60M 10-Q · filed 2014-05-15 | $8.27M derived: sum of 2 quarters · filed 2014-05-15 | $9.81M derived: sum of 3 quarters · filed 2014-11-14 | $8.96M derived: sum of 4 quarters · filed 2014-11-14 |
| 2013-12-31 | $3.67M derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-31 | $5.21M derived: sum of 2 quarters · filed 2014-11-14 | $4.36M derived: sum of 3 quarters · filed 2014-11-14 | -$5.42M 10-K · filed 2014-03-31 |
| 2013-09-30 | $1.54M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-14 | $690.53K derived: sum of 2 quarters · filed 2014-11-14 | -$9.09M 10-Q · filed 2014-11-14 | |
| 2013-06-30 | -$851.95K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-14 | -$10.63M 10-Q · filed 2014-08-14 | ||
| 2013-03-31 | -$9.78M 10-Q · filed 2014-05-15 | |||
| 2012-12-31 | $6.55M 10-K · filed 2014-03-31 |